To validate the misregulation of tau in ARSACS and establish a platform from which to explore therapeutic targeting of proteins involved in tau pathology as a treatment for ARSACS.

Grant: $98,758

Dr. Anthony Hickey, Director of UNC Catalyst for Rare Diseases, University of North Carolina                        120 Mason Farm Road CB# 7356 Chapel Hill NC 27599
Tel: (919) 962-9819